Through its publications, INSS provides rigorous, forward‑looking research and analysis on critical national security issues that support the joint warfighter and inform Department of War decision‑makers.
Dec. 17, 2025
Biotechnology in the FY 2026 NDAA: Strategic Implications — and Recommendations — for Joint Force Readiness
The newly released FY 26 NDAA places explicit emphasis upon the increasing involvement of biotechnology in US military missions. As 2025 comes to a close, and we look ahead to the new year, Dr. James Giordano, Director of the CDTFW, offers a view to why biotechnology is — and will be ever more — intrinsic and important to national defense and offers a set of recommendations for fortifying Joint Force engagement in the biotechnological domain.